choline has been researched along with Disbacteriosis in 17 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 8.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, inflammation, and fibrosis, as well as gut dysbiosis." | 5.91 | Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice. ( Gong, F; Jia, S; Li, X; Lin, D; Liu, Z; Pan, J; Sun, Q; Wang, S; Zheng, M; Zhu, J, 2023) |
| "The available literature has proposed mechanisms for an association between gut microbiota and NASH, such as: modification energy homeostasis, lipopolysaccharides (LPS)-endotoxemia, increased endogenous production of ethanol, and alteration in the metabolism of bile acid and choline." | 4.98 | Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis. ( Cesar, DE; de Castro Ferreira, LEVV; de Faria Ghetti, F; de Oliveira, JM; Moreira, APB; Oliveira, DG, 2018) |
| "Trimethylamine-N-oxide (TMAO), a derivative from the gut microbiota metabolite trimethylamine (TMA), has been identified to be an independent risk factor for promoting atherosclerosis." | 4.02 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. ( Du, Y; Hong, B; Jiang, J; Jiang, Z; Li, X; Su, C; Wang, L; Yang, M; Yang, Y; Zhang, J; Zhang, X; Zhang, Y, 2021) |
| "Trimethylamine-N-oxide (TMAO), a gut-microbiota-dependent metabolite generated from its dietary precursors such as choline, has been identified as an independent risk factor for atherosclerosis." | 4.02 | Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality. ( Du, Y; Hong, B; Li, X; Su, C; Wang, L; Yang, Y; Zhang, X, 2021) |
| "Choline is a water-soluble nutrient essential for human life." | 2.66 | The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. ( Allison, J; Arboleya, S; Arias, JL; Arias, N; Gueimonde, M; Higarza, SG; Kaliszewska, A, 2020) |
| "Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis, inflammation, and fibrosis, as well as gut dysbiosis." | 1.91 | Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice. ( Gong, F; Jia, S; Li, X; Lin, D; Liu, Z; Pan, J; Sun, Q; Wang, S; Zheng, M; Zhu, J, 2023) |
| "Gut microbiota dysbiosis is associated with the development of non-alcoholic steatohepatitis (NASH) through modulation of gut barrier, inflammation, lipid metabolism, bile acid signaling and short-chain fatty acid production." | 1.72 | Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model. ( Ahmad, HFB; Christoffersen, BØ; Cirera, S; Geng, D; Hansen, AK; Hyötyläinen, T; Jakobsen, RR; Kot, W; Lützhøft, DO; Nielsen, DS; Pedersen, HD; Pedersen, KM; Sinioja, T; Straarup, EM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 11 (64.71) | 2.80 |
| Authors | Studies |
|---|---|
| Bin-Jumah, MN | 1 |
| Gilani, SJ | 1 |
| Hosawi, S | 1 |
| Al-Abbasi, FA | 1 |
| Zeyadi, M | 1 |
| Imam, SS | 1 |
| Alshehri, S | 1 |
| Ghoneim, MM | 1 |
| Nadeem, MS | 1 |
| Kazmi, I | 1 |
| Lützhøft, DO | 3 |
| Sinioja, T | 3 |
| Christoffersen, BØ | 3 |
| Jakobsen, RR | 3 |
| Geng, D | 3 |
| Ahmad, HFB | 3 |
| Straarup, EM | 3 |
| Pedersen, KM | 3 |
| Kot, W | 3 |
| Pedersen, HD | 3 |
| Cirera, S | 3 |
| Hyötyläinen, T | 3 |
| Nielsen, DS | 3 |
| Hansen, AK | 3 |
| Lin, D | 1 |
| Sun, Q | 1 |
| Liu, Z | 1 |
| Pan, J | 1 |
| Zhu, J | 1 |
| Wang, S | 2 |
| Jia, S | 1 |
| Zheng, M | 1 |
| Li, X | 3 |
| Gong, F | 1 |
| Nakamura, S | 1 |
| Nakamura, K | 1 |
| Yokoi, Y | 1 |
| Shimizu, Y | 1 |
| Ohira, S | 1 |
| Hagiwara, M | 1 |
| Song, Z | 1 |
| Gan, L | 1 |
| Aizawa, T | 1 |
| Hashimoto, D | 1 |
| Teshima, T | 1 |
| Ouellette, AJ | 1 |
| Ayabe, T | 1 |
| Hernandez, GV | 1 |
| Smith, VA | 1 |
| Melnyk, M | 1 |
| Burd, MA | 1 |
| Sprayberry, KA | 1 |
| Edwards, MS | 1 |
| Peterson, DG | 1 |
| Bennet, DC | 1 |
| Fanter, RK | 1 |
| Columbus, DA | 1 |
| Steibel, JP | 1 |
| Glanz, H | 1 |
| Immoos, C | 1 |
| Rice, MS | 1 |
| Santiago-Rodriguez, TM | 1 |
| Blank, J | 1 |
| VanderKelen, JJ | 1 |
| Kitts, CL | 1 |
| Piccolo, BD | 1 |
| La Frano, MR | 1 |
| Burrin, DG | 1 |
| Maj, M | 1 |
| Manjarin, R | 1 |
| Koay, YC | 1 |
| Chen, YC | 1 |
| Wali, JA | 1 |
| Luk, AWS | 1 |
| Li, M | 1 |
| Doma, H | 1 |
| Reimark, R | 1 |
| Zaldivia, MTK | 1 |
| Habtom, HT | 1 |
| Franks, AE | 1 |
| Fusco-Allison, G | 1 |
| Yang, J | 1 |
| Holmes, A | 1 |
| Simpson, SJ | 1 |
| Peter, K | 1 |
| O'Sullivan, JF | 1 |
| Arias, N | 1 |
| Arboleya, S | 1 |
| Allison, J | 1 |
| Kaliszewska, A | 1 |
| Higarza, SG | 1 |
| Gueimonde, M | 1 |
| Arias, JL | 1 |
| Mungamuri, SK | 1 |
| Vijayasarathy, K | 1 |
| Baragetti, A | 1 |
| Severgnini, M | 1 |
| Olmastroni, E | 1 |
| Dioguardi, CC | 1 |
| Mattavelli, E | 1 |
| Angius, A | 1 |
| Rotta, L | 1 |
| Cibella, J | 1 |
| Caredda, G | 1 |
| Consolandi, C | 1 |
| Grigore, L | 1 |
| Pellegatta, F | 1 |
| Giavarini, F | 1 |
| Caruso, D | 1 |
| Norata, GD | 1 |
| Catapano, AL | 1 |
| Peano, C | 1 |
| Su, C | 2 |
| Jiang, Z | 1 |
| Yang, Y | 2 |
| Zhang, Y | 1 |
| Yang, M | 1 |
| Zhang, X | 2 |
| Du, Y | 2 |
| Zhang, J | 1 |
| Wang, L | 2 |
| Jiang, J | 1 |
| Hong, B | 2 |
| Shen, TD | 1 |
| Xu, KY | 1 |
| Xia, GH | 1 |
| Lu, JQ | 1 |
| Chen, MX | 1 |
| Zhen, X | 1 |
| You, C | 1 |
| Nie, J | 1 |
| Zhou, HW | 1 |
| Yin, J | 1 |
| de Faria Ghetti, F | 1 |
| Oliveira, DG | 1 |
| de Oliveira, JM | 1 |
| de Castro Ferreira, LEVV | 1 |
| Cesar, DE | 1 |
| Moreira, APB | 1 |
| Freedman, SN | 1 |
| Shahi, SK | 1 |
| Mangalam, AK | 1 |
| Zhao, Y | 1 |
| Wu, J | 1 |
| Li, JV | 1 |
| Zhou, NY | 1 |
| Tang, H | 1 |
| Wang, Y | 1 |
| Srinivasa, S | 1 |
| Fitch, KV | 1 |
| Lo, J | 1 |
| Kadar, H | 1 |
| Knight, R | 1 |
| Wong, K | 1 |
| Abbara, S | 1 |
| Gauguier, D | 1 |
| Capeau, J | 1 |
| Boccara, F | 1 |
| Grinspoon, SK | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Washed Microbiota Transplantation (WMT) for Chronic Kidney Disease (CKD): a Open Label, Multicenter Trial[NCT05838118] | 100 participants (Anticipated) | Interventional | 2023-04-20 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for choline and Disbacteriosis
| Article | Year |
|---|---|
Pathobiological Relationship of Excessive Dietary Intake of Choline/L-Carnitine: A TMAO Precursor-Associated Aggravation in Heart Failure in Sarcopenic Patients.
Topics: Biodiversity; Biomarkers; Carnitine; Choline; Dietary Supplements; Disease Susceptibility; Dysbiosis | 2021 |
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.
Topics: Animals; Biological Availability; Cardiovascular Diseases; Choline; Diet; Dysbiosis; Gastrointestina | 2020 |
Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease Progression.
Topics: Animals; Choline; Disease Progression; Dysbiosis; Fecal Microbiota Transplantation; Gastrointestinal | 2020 |
Diet and Gut Microbiota in Health and Disease.
Topics: Animals; Bacteria; Choline; Diet; Dietary Carbohydrates; Dysbiosis; Fecal Microbiota Transplantation | 2017 |
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
Topics: Animals; Bile Acids and Salts; Choline; Diet; Disease Progression; Dysbiosis; Endotoxemia; Energy In | 2018 |
The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.
Topics: Animals; Autoimmunity; Bile Acids and Salts; Choline; Dysbiosis; Fatty Acids, Volatile; Gastrointest | 2018 |
11 other studies available for choline and Disbacteriosis
| Article | Year |
|---|---|
Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model.
Topics: Amino Acids; Animals; Choline; Dysbiosis; Gastrointestinal Microbiome; Male; Non-alcoholic Fatty Liv | 2022 |
Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model.
Topics: Amino Acids; Animals; Choline; Dysbiosis; Gastrointestinal Microbiome; Male; Non-alcoholic Fatty Liv | 2022 |
Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model.
Topics: Amino Acids; Animals; Choline; Dysbiosis; Gastrointestinal Microbiome; Male; Non-alcoholic Fatty Liv | 2022 |
Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model.
Topics: Amino Acids; Animals; Choline; Dysbiosis; Gastrointestinal Microbiome; Male; Non-alcoholic Fatty Liv | 2022 |
Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
Topics: Animals; Bile Acids and Salts; Choline; Diet; Dysbiosis; Gastrointestinal Microbiome; Liver; Methion | 2023 |
Decreased Paneth cell α-defensins promote fibrosis in a choline-deficient L-amino acid-defined high-fat diet-induced mouse model of nonalcoholic steatohepatitis via disrupting intestinal microbiota.
Topics: alpha-Defensins; Amino Acids; Animals; Choline; Diet, High-Fat; Dysbiosis; Gastrointestinal Microbio | 2023 |
Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH.
Topics: Age Factors; Animals; Bile Acids and Salts; Choline; Colon; Disease Models, Animal; Dysbiosis; Femal | 2020 |
Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.
Topics: Animal Feed; Animals; Atherosclerosis; Bacteria; Biomarkers; Carotid Artery Diseases; Choline; Coron | 2021 |
Gut Microbiota Functional Dysbiosis Relates to Individual Diet in Subclinical Carotid Atherosclerosis.
Topics: Adult; Aged; Aged, 80 and over; Bacteria; Carnitine; Carotid Artery Diseases; Choline; Diet; Dysbios | 2021 |
Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome.
Topics: Animals; Atherosclerosis; Berberine; Choline; Diet; Disease Models, Animal; Disease Susceptibility; | 2021 |
Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality.
Topics: Akkermansia; Animals; Atherosclerosis; Bifidobacterium; Choline; Diabetes Mellitus, Type 2; Diet; Dy | 2021 |
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.
Topics: Adult; Aged; Animals; Betaine; Carnitine; Case-Control Studies; Choline; Clostridiaceae; Dysbiosis; | 2017 |
Gut microbiota composition modifies fecal metabolic profiles in mice.
Topics: Amino Acids; Animals; Bile Acids and Salts; Ceftriaxone; Choline; Dysbiosis; Feces; Female; Gentamic | 2013 |
Plaque burden in HIV-infected patients is associated with serum intestinal microbiota-generated trimethylamine.
Topics: Choline; Coronary Artery Disease; Dysbiosis; Female; HIV Infections; Humans; Intestinal Diseases; Ma | 2015 |